No. |
DrugBank |
Drug (Description in trials) [Number of descriptions] |
KEGG DRUG * | KEGG GENES * [Number of genes] |
KEGG PATHWAY [Number of pathways] |
Disease ID * [Number of diseases] |
1 | Bardoxolone | [4] Bardoxolone; Bardoxolone methyl; Bardoxolone methyl capsules; Bardoxolone methyl oral capsule; | D09584 |
- |
- |
[7] 66, 67, 84, 85, 86, 218, 222 |
2 | Bardoxolone methyl | [3] Bardoxolone methyl; Bardoxolone methyl capsules; Bardoxolone methyl oral capsule; | D09585 |
- |
- |
[7] 66, 67, 84, 85, 86, 218, 222 |
3 | Benazepril | [3] Benazepril; Benazepril hydrochloride tablets; Benazepril, valsartan and fluvastatin; | D00620 D07499 |
[1] ACE |
[4] Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system |
[3] 57, 218, 224 |
4 | Fluvastatin | [2] Benazepril, valsartan and fluvastatin; Fluvastatin; | D00892 D07983 |
[1] HMGCR |
[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
[3] 79, 218, 222 |
5 | Paricalcitol | [1] Paricalcitol; | D00930 |
[1] VDR |
[4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
[3] 19, 66, 218 |
6 | Ramipril | [1] Ramipril; | D00421 |
[1] ACE |
[4] Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM), Renin secretion, Renin-angiotensin system |
[7] 46, 49, 66, 67, 113, 218, 257 |
7 | Spironolactone | [4] Ambrisentan plus spironolactone; Spironolactone; Spironolactone and conivaptan; Spironolactone captopril carvedilol; | D00443 |
[1] NR3C2 |
[1] Aldosterone-regulated sodium reabsorption |
[6] 58, 67, 86, 113, 218, 225 |
8 | Valsartan | [4] Benazepril, valsartan and fluvastatin; Enalapril valsartan methylprednisone; Sacubitril/valsartan; Valsartan; | D00400 |
[1] AGTR1 |
[14] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
[6] 57, 58, 66, 75, 218, 222 |